Keywords: actos, cuts, atherosclerosis, type, diabetics, new, data

Actos cuts atherosclerosis in type 2 diabetics

Article | 07 April 2008

New data from a clinical trial using intravascular ultrasound technology found that, in patients living with type 2 diabetes, Takeda's Actos ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Actos

Pioglitazone

Amaryl

Glimepiride

Go to drug listing